- Investing Ideas
- /
- Pakistani Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals
Pakistani Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals
Results
5
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
5 companies
Searle
Market Cap: PK₨74.1b
Manufactures and sells pharmaceutical and other consumer products in Pakistan, Sri Lanka, Myanmar, Cambodia, Vietnam, Iraq, Oman, Afghanistan, Tajikistan, Laos, Kenya, and internationally.
SEARL
PK₨124.97
7D
-2.0%
1Y
28.5%
Highnoon Laboratories
Market Cap: PK₨55.8b
Manufactures, imports, sells, exports, and markets pharmaceutical and allied consumer products.
HINOON
PK₨1,030.83
7D
0.2%
1Y
13.5%
Hoechst Pakistan
Market Cap: PK₨42.1b
Engages in the manufacture, trading, and sale of pharmaceutical and related products in Pakistan, Afghanistan, and internationally.
HPL
PK₨4,442.86
7D
5.2%
1Y
43.7%
Abbott Laboratories (Pakistan)
Market Cap: PK₨117.1b
Manufactures, imports, and markets generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products in Pakistan, Afghanistan, Sri Lanka, Bangladesh, and Switzerland.
ABOT
PK₨1,189.70
7D
-1.7%
1Y
-7.2%
GlaxoSmithKline Pakistan
Market Cap: PK₨136.9b
Operates as a biopharma company in Pakistan.
GLAXO
PK₨432.61
7D
0.9%
1Y
4.1%